Template:Bladder cancer: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(8 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" | {| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:DarkGray" | | | colspan="1" style="text-align:center; background:DarkGray" | | ||
Bladder cancer Microchapters | |||
''' | ''' | ||
|- bgcolor="LightGrey" | |- bgcolor="LightGrey" | ||
Line 13: | Line 11: | ||
! | ! | ||
[[Bladder cancer|Home]] | [[Bladder cancer|Home]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Bladder cancer (patient information)|Patient | [[Bladder cancer (patient information)|Patient Information]] | ||
|- | |- | ||
! | ! | ||
Line 25: | Line 23: | ||
! | ! | ||
[[Bladder cancer overview|Overview]] | [[Bladder cancer overview|Overview]] | ||
|- | |- | ||
! | ! | ||
Line 31: | Line 29: | ||
! | ! | ||
[[Bladder cancer historical perspective|Historical Perspective]] | [[Bladder cancer historical perspective|Historical Perspective]] | ||
|- | |- | ||
! | ! | ||
Line 37: | Line 35: | ||
! | ! | ||
[[Bladder cancer classification|Classification]] | [[Bladder cancer classification|Classification]] | ||
|- | |- | ||
! | ! | ||
Line 43: | Line 41: | ||
! | ! | ||
[[Bladder cancer pathophysiology|Pathophysiology]] | [[Bladder cancer pathophysiology|Pathophysiology]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Bladder cancer | [[Bladder cancer causes|Causes]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Bladder cancer | [[Bladder cancer differential diagnosis|Differentiating Bladder cancer from other Diseases]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Bladder cancer | [[Bladder cancer epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Bladder cancer | [[Bladder cancer risk factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Bladder cancer | [[Bladder cancer screening|Screening]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Bladder cancer natural history|Natural History, Complications | [[Bladder cancer natural history, complications and prognosis|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! | ||
Line 85: | Line 81: | ||
! | ! | ||
Diagnosis | Diagnosis | ||
|- | |- | ||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Bladder cancer staging|Staging]] | |||
|- | |||
! | ! | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Bladder cancer history and symptoms|History | [[Bladder cancer diagnostic study of choice|Diagnostic Study of Choice]] | ||
|- | |- | ||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Bladder cancer history and symptoms|History and Symptoms]] | |||
|- | |||
! | ! | ||
Line 97: | Line 105: | ||
! | ! | ||
[[Bladder cancer physical examination|Physical Examination]] | [[Bladder cancer physical examination|Physical Examination]] | ||
|- | |- | ||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Bladder cancer laboratory findings|Laboratory Findings]] | |||
|- | |||
! | ! | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Bladder cancer | [[Bladder cancer electrocardiogram|Electrocardiogram]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Bladder cancer | [[Bladder cancer X Ray|X Ray]] | ||
|- | |- | ||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Bladder cancer CT|CT]] | |||
|- | |||
! | ! | ||
Line 115: | Line 135: | ||
! | ! | ||
[[Bladder cancer MRI|MRI]] | [[Bladder cancer MRI|MRI]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Bladder cancer | [[Bladder cancer echocardiography or ultrasound|Electrocardiography or Ultrasound]] | ||
|- | |- | ||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Bladder cancer other imaging findings|Other Imaging Findings]] | |||
|- | |||
! | ! | ||
Line 127: | Line 153: | ||
! | ! | ||
[[Bladder cancer other diagnostic studies|Other Diagnostic Studies]] | [[Bladder cancer other diagnostic studies|Other Diagnostic Studies]] | ||
|- | |- | ||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Bladder cancer biopsy|Biopsy]] | |||
|- | |||
! | ! | ||
|- bgcolor="CadetBlue" | |- bgcolor="CadetBlue" | ||
! | ! | ||
Treatment | |||
|- | |- | ||
! | ! | ||
Line 139: | Line 171: | ||
! | ! | ||
[[Bladder cancer medical therapy|Medical Therapy]] | [[Bladder cancer medical therapy|Medical Therapy]] | ||
|- | |- | ||
! | ! | ||
Line 145: | Line 177: | ||
! | ! | ||
[[Bladder cancer surgery|Surgery]] | [[Bladder cancer surgery|Surgery]] | ||
|- | |- | ||
! | ! | ||
Line 151: | Line 183: | ||
! | ! | ||
[[Bladder cancer primary prevention|Primary Prevention]] | [[Bladder cancer primary prevention|Primary Prevention]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Bladder cancer secondary prevention|Secondary Prevention]] | [[Bladder cancer secondary prevention|Secondary Prevention]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Bladder cancer cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Bladder cancer cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Bladder cancer future or investigational therapies|Future or Investigational Therapies]] | [[Bladder cancer future or investigational therapies|Future or Investigational Therapies]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="CadetBlue" | |- bgcolor="CadetBlue" | ||
Line 180: | Line 212: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Bladder cancer case study one|Case #1]] | ||
|- | |- | ||
! | ! | ||
Line 187: | Line 219: | ||
! | ! | ||
{{PAGENAME}} On the Web | {{PAGENAME}} On the Web | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} Most recent articles] | [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} Most recent articles] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://scholar.google.com/scholar?ie=UTF-8&oe=utf-8&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&qt_s=Search&sa=N&tab= | [http://scholar.google.com/scholar?ie=UTF-8&oe=utf-8&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&qt_s=Search&sa=N&tab=ps Most cited articles] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}%20AND%20systematic%5Bsb%5D Review articles] | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}%20AND%20systematic%5Bsb%5D Review articles] | ||
|- | |- | ||
! | ! | ||
Line 211: | Line 243: | ||
! | ! | ||
[http://www.google.com/search?hl=en&client=firefox-a&rls=org.mozilla:en-US:official&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+more:health_continuing_education&cx=disease_for_health_professionals&sa=N&oi=coopctx&resnum=0&ct=col3&cd=2 CME Programs] | [http://www.google.com/search?hl=en&client=firefox-a&rls=org.mozilla:en-US:official&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+more:health_continuing_education&cx=disease_for_health_professionals&sa=N&oi=coopctx&resnum=0&ct=col3&cd=2 CME Programs] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://www.google.com/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+ppt&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a Powerpoint slides] | [http://www.google.com/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+ppt&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a Powerpoint slides] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://images.google.com/images?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wi Images] | [http://images.google.com/images?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wi Images] | ||
|- | |- | ||
! | ! | ||
Line 234: | Line 266: | ||
:[http://goldminer.arrs.org/search.php?query={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}} CT}}}} CT Images] | :[http://goldminer.arrs.org/search.php?query={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}} CT}}}} CT Images] | ||
:[http://goldminer.arrs.org/search.php?query={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}} MRI}}}} MRI] | :[http://goldminer.arrs.org/search.php?query={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}} MRI}}}} MRI] | ||
|- | |- | ||
! | ! | ||
Line 240: | Line 272: | ||
! | ! | ||
[http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} Ongoing Trials at Clinical Trials.gov] | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} Ongoing Trials at Clinical Trials.gov] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://www.guideline.gov/search/searchresults.aspx?Type=3&txtSearch={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&num=20 US National Guidelines Clearinghouse] | [http://www.guideline.gov/search/searchresults.aspx?Type=3&txtSearch={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&num=20 US National Guidelines Clearinghouse] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://www.nice.org.uk/search/guidancesearchresults.jsp?keywords={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&searchType=guidance NICE Guidance] | [http://www.nice.org.uk/search/guidancesearchresults.jsp?keywords={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&searchType=guidance NICE Guidance] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://google2.fda.gov/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&x=0&y=0&client=FDA&site=FDA&lr=&proxystylesheet=FDA&output=xml_no_dtd&getfields=* FDA on {{PAGENAME}}] | [http://google2.fda.gov/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&x=0&y=0&client=FDA&site=FDA&lr=&proxystylesheet=FDA&output=xml_no_dtd&getfields=* FDA on {{PAGENAME}}] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://www.cdc.gov/search.do?queryText={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&searchButton.x=33&searchButton.y=6&action=search CDC on {{PAGENAME}}] | [http://www.cdc.gov/search.do?queryText={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&searchButton.x=33&searchButton.y=6&action=search CDC on {{PAGENAME}}] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://news.google.com/news?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wn {{PAGENAME}} in the news] | [http://news.google.com/news?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wn {{PAGENAME}} in the news] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}]</small> | [http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}]</small> | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+ | [http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Bladder cancer}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab=wl Directions to Hospitals Treating Bladder cancer] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://www.google.com/search?hl=en&client=firefox-a&rls=org.mozilla%3Aen-US%3Aofficial&hs=QWo&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+AND+risk+score+OR+risk+calculator&btnG=Search Risk calculators and risk factors for {{PAGENAME}}] | [http://www.google.com/search?hl=en&client=firefox-a&rls=org.mozilla%3Aen-US%3Aofficial&hs=QWo&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+AND+risk+score+OR+risk+calculator&btnG=Search Risk calculators and risk factors for {{PAGENAME}}] | ||
|- | |- | ||
! | ! | ||
|} | |} |
Latest revision as of 15:14, 13 April 2018
Bladder cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Bladder cancer On the Web |
American Roentgen Ray Society Images of Bladder cancer |